Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Basket Study of Entrectinib (RXDX-101) · Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Trial completed Hoffmann-La RochePhase 2 NCT02568267
  2. Minor: Tirbanibulin for Pediatric Warts Trial completed The Skin Center Dermatology GroupPhase 4 NCT06791525
  3. Minor: ENV-101 · Lung Fibrosis (WHISTLE-PF Trial) Trial completed Endeavor Biomedicines, Inc.Phase 2 NCT06422884
  4. Minor: Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, · Obesity or Overweight Trial completed Eli Lilly and CompanyPhase 2 NCT06643728
  5. Minor: Eloralintide (LY3841136) in Healthy Participants Trial completed Eli Lilly and CompanyPhase 1 NCT07701083
  6. Minor: Eloralintide (LY3841136) · Obesity or Overweight Enrollment closed, study ongoing Eli Lilly and CompanyPhase 1 NCT07738614
  7. Minor: Gene Therapy Drug · Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis Enrollment closed, study ongoing GeneCradle IncPhase 1 NCT05860569
  8. Minor: SL-325 in Healthy Volunteers Trial completed Shattuck Labs, Inc.Phase 1 NCT07158437
  9. Minor: Migaldendranib in Healthy Volunteers Trial completed Ashvattha Therapeutics, Inc.Phase 1 NCT07370155
  10. Minor: Eloralintide (LY3841136) · Renal Impairment and in Participants With Normal Renal Function Trial completed Eli Lilly and CompanyPhase 1 NCT07426380
  11. Minor: Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief Trial completed HALEONNot applicable NCT07300540
  12. Minor: DOT Spectacles in Chinese Children Extension Enrollment closed, study ongoing SightGlass Vision, Inc.Not applicable NCT07008001
  13. Minor: Collection of Blood Samples for New Diagnostic Devices 2 Trial completed LumiraDx UK LimitedNot specified NCT05568966
  14. Minor: Korean Post-marketing Surveillance for Xeljanz XR Trial completed PfizerNot specified NCT04876781
  15. Minor: Activia Kefir Consumption in Real-world Setting Enrollment closed, study ongoing Danone Global Research & Innovation CenterNot specified NCT07790666
  16. Minor: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing Enrollment closed, study ongoing A2 Biotherapeutics Inc.Not specified NCT04981119
  17. Minor: Specific Gait Patterns · Multiple Sclerosis Trial completed SYSNAVNot specified NCT07388992
  18. Minor: Etrasimod · Moderate to Severe Ulcerative Colitis Enrollment closed, study ongoing PfizerNot specified NCT06398626
  19. Minor: Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease Trial completed AbbVieNot specified NCT06937034
  20. Minor: Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea Enrollment closed, study ongoing Novartis PharmaceuticalsNot specified NCT05703516
  21. Minor: Iovera®° System · Upper Extremity Spasticity Trial completed Pacira Pharmaceuticals, IncNot applicable NCT06340451
  22. Minor: SPN-812 (Viloxazine Extended-release Capsule) Primary and study completion pushed from Sep 2026 to Dec 2026 Supernus Pharmaceuticals, Inc.Phase 3 NCT02736656
  23. Minor: Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy Enrollment closed, study ongoing Masahisa KatsunoPhase 2/3 NCT06862596
  24. Minor: AZA+Lus VS AZA Monotherapy in HR-MDS Completed without a posted recruiting period Peking Union Medical College HospitalPhase 3 NCT06927232
  25. Minor: Recurrent Breast Cancer and Repeated Radiation Therapy Enrollment closed, study ongoing Turku University HospitalNot applicable NCT06704659